Plc Astrazeneca's Net Worth

$812 Million

Estimate Recalculated Feb 7, 2024 03:49PM EST

Who is Plc Astrazeneca?

Plc Astrazeneca has an estimated net worth of $812 Million. This is based on reported shares across multiple companies, which include Viela Bio, Inc., Aevi Genomic Medicine, Inc., PhaseBio Pharmaceuticals Inc, Entasis Therapeutics Holdings Inc., ALBIREO PHARMA, INC., Regulus Therapeutics Inc., and Ardea Biosciences, Inc./DE.

SEC CIK

Plc Astrazeneca's CIK is 0000901832

Past Insider Trading and Trends

2018 was Plc Astrazeneca's most active year for acquiring shares with 5 total transactions. Plc Astrazeneca's most active month to acquire stocks was the month of September. 2018 was Plc Astrazeneca's most active year for disposing of shares, totalling 5 transactions. Plc Astrazeneca's most active month to dispose stocks was the month of September. 2019 saw Plc Astrazeneca paying a total of $8,075,000.00 for 27,597,224 shares, this is the most they've acquired in one year. In 2021 Plc Astrazeneca cashed out on 14,650,334 shares for a total of $776,467,702.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Viela Bio, Inc. No price found

Investor

Plc Astrazeneca used to own units in Common Stock but no longer holds any shares there. From 2019 to 2021 Plc Astrazeneca acquired a total of 14,650,324 shares in Viela Bio, Inc. at a cost of $8,075,000.00, Plc also disposed a total of 14,650,334 shares of Viela Bio, Inc. equalling to $776,467,702.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-14.65M
$53.00
-$776,467,702.00
0
Mar 15
Form 4
+146,503,240.00%
14.65M
$19.00
14.65M
Oct 7
Form 3/A
0
0
Form 3
0
0
No matching records found

Aevi Genomic Medicine, Inc. No price found

Investor

Plc Astrazeneca owns 12,946,900 units of Common Stock. In the year 2020 Plc Astrazeneca filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
12.95M
12.95M
Dec 19
Form 3
0
0
No matching records found

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.0002

Investor

Plc Astrazeneca owns 3,004,554 units of Common Stock which is worth $600.91. In the year 2018 Plc Astrazeneca filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3M
$5.00
3M
Oct 22
Form 3
0
0
No matching records found

Entasis Therapeutics Holdings Inc. No price found

Investor

Plc Astrazeneca owns 2,164,855 units of Common Stock. In the year 2018 Plc Astrazeneca filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+54,121,275.00%
2.16M
$15.00
2.16M
Sep 28
Form 3
0
0
No matching records found

ALBIREO PHARMA, INC. No price found

Investor

Plc Astrazeneca owns 508,141 units of Common Stock, $0.01 par value per share. In the year 2016 Plc Astrazeneca disposed a total of 500,000 shares of ALBIREO PHARMA, INC. equalling to $10,700,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-49.60%
-500.00K
$21.40
-$10,700,000.00
508.14K
Dec 1
Form 3
0
0
No matching records found